Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin

Susan Boyle-Vavra1, Robert S Daum

  • 1Department of Pediatrics, Section of Infectious Diseases, University of Chicago, Chicago, IL 60637, USA. sboyle@peds.bsd.uchicago.edu

Insights

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is an epidemic causing severe infections. These strains appear distinct from hospital-acquired MRSA and may be more virulent, partly due to Panton-Valentine Leukocidin (PVL).

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections have emerged as a significant epidemic.
  • CA-MRSA causes severe, rapidly progressive diseases like necrotizing pneumonia, sepsis, and fasciitis, particularly in individuals without healthcare-associated risk factors.
  • Unlike hospital-acquired MRSA (HA-MRSA), CA-MRSA strains are often susceptible to non-beta-lactam antibiotics.

Purpose of the Study:

  • To present evidence suggesting CA-MRSA are distinct strains emerging independently from community-susceptible isolates.
  • To explore the hypothesis that CA-MRSA may possess increased virulence compared to HA-MRSA.
  • To outline advancements in understanding the role of Panton-Valentine Leukocidin (PVL) in CA-MRSA pathogenesis.

Main Methods:

  • Comparative analysis of CA-MRSA and HA-MRSA isolates.
  • Investigation of genetic elements, including novel methicillin resistance cassettes and PVL phage.
  • Review of existing data on PVL's contribution to MRSA virulence.

Main Results:

  • Evidence supports CA-MRSA as distinct strains originating de novo within the community.
  • CA-MRSA isolates may exhibit greater virulence than HA-MRSA.
  • Panton-Valentine Leukocidin (PVL) is frequently harbored by CA-MRSA and implicated in enhanced virulence.

Conclusions:

  • CA-MRSA represents a unique and concerning public health threat.
  • The distinct origin and potential for increased virulence of CA-MRSA warrant further investigation.
  • Understanding the role of PVL is crucial for developing effective therapeutic and preventative strategies against CA-MRSA infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...